Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

White matter hyperintensities: relationship to amyloid and tau burden.

Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, Gunter JL, Senjem ML, Przybelski SA, Lesnick T, Ward C, Mielke MM, Lowe VJ, Petersen RC, Kremers WK, Kantarci K, Jack CR, Vemuri P.

Brain. 2019 Jun 14. pii: awz162. doi: 10.1093/brain/awz162. [Epub ahead of print]

PMID:
31199475
2.

Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers.

Chen Q, Boeve BF, Tosakulwong N, Lesnick T, Brushaber D, Dheel C, Fields J, Forsberg L, Gavrilova R, Gearhart D, Haley D, Gunter JL, Graff-Radford J, Jones D, Knopman D, Graff-Radford N, Kraft R, Lapid M, Rademakers R, Wszolek ZK, Rosen H, Boxer AL, Kantarci K.

J Neuroimaging. 2019 Jun 7. doi: 10.1111/jon.12642. [Epub ahead of print]

PMID:
31173437
3.

Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults.

Lowe VJ, Bruinsma TJ, Wiste HJ, Min HK, Weigand SD, Fang P, Senjem ML, Therneau TM, Boeve BF, Josephs KA, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.

Neurology. 2019 May 30. pii: 10.1212/WNL.0000000000007728. doi: 10.1212/WNL.0000000000007728. [Epub ahead of print]

PMID:
31147421
4.

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

Staffaroni AM, Bajorek L, Casaletto KB, Cobigo Y, Goh SM, Wolf A, Heuer HW, Elahi FM, Ljubenkov PA, Dever R, Kornak J, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dheel C, Dickerson BC, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fields JA, Fishman A, Fong J, Foroud T, Forsberg LK, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung GY, Huey ED, Irwin DJ, Jones DT, Jones L, Kantarci K, Karydas A, Kaufer DI, Kerwin DR, Knopman DS, Kraft R, Kremers WK, Kukull WA, Litvan I, Lucente D, Lungu C, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley E, Mendez MF, Miller BL, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wang P, Wong B, Wszolek Z, Boxer AL, Boeve BF, Kramer JH, Rosen HJ; ARTFL/LEFFTDS consortium.

Alzheimers Dement. 2019 May 11. pii: S1552-5260(19)30044-5. doi: 10.1016/j.jalz.2019.01.012. [Epub ahead of print]

5.

Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.

Sintini I, Martin PR, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, Spychalla AJ, Drubach DA, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL.

Neuroimage Clin. 2019 Apr 10;23:101823. doi: 10.1016/j.nicl.2019.101823. [Epub ahead of print]

6.

CSF1R mutation presenting as dementia with Lewy bodies.

Sharma R, Graff-Radford J, Rademakers R, Boeve BF, Petersen RC, Jones DT.

Neurocase. 2019 Feb - Apr;25(1-2):17-20. doi: 10.1080/13554794.2019.1601230. Epub 2019 Apr 10.

PMID:
30968732
7.

The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Whitwell JL, Martin P, Graff-Radford J, Machulda MM, Senjem ML, Schwarz CG, Weigand SD, Spychalla AJ, Drubach DA, Jack CR Jr, Lowe VJ, Josephs KA.

Alzheimers Dement. 2019 May;15(5):675-685. doi: 10.1016/j.jalz.2018.12.016. Epub 2019 Mar 8.

PMID:
30853465
8.

The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.

Arenaza-Urquijo EM, Przybelski SA, Lesnick TL, Graff-Radford J, Machulda MM, Knopman DS, Schwarz CG, Lowe VJ, Mielke MM, Petersen RC, Jack CR, Vemuri P.

Brain. 2019 Apr 1;142(4):1134-1147. doi: 10.1093/brain/awz037.

PMID:
30851100
9.

Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects.

Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Boeve BF, Jones DT, Graff-Radford J, Albertson SM, Schwarz CG, Petersen RC, Jack CR.

Brain. 2019 Apr 1;142(4):1148-1160. doi: 10.1093/brain/awz025.

PMID:
30759182
10.

Excessive Daytime Sleepiness in Major Dementia Syndromes.

Boeve A, Ferman TJ, Aakre J, St Louis E, Silber M, Machulda M, Fields J, Graff-Radford N, Mielke M, Geda Y, Jones D, Graff-Radford J, Knopman D, Petersen R, Boeve B.

Am J Alzheimers Dis Other Demen. 2019 Jun;34(4):261-264. doi: 10.1177/1533317519828046. Epub 2019 Feb 10.

PMID:
30740984
11.

Vascular Cognitive Impairment.

Graff-Radford J.

Continuum (Minneap Minn). 2019 Feb;25(1):147-164. doi: 10.1212/CON.0000000000000684.

PMID:
30707191
12.

The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia.

Whitwell JL, Martin PR, Duffy JR, Clark HM, Machulda MM, Schwarz CG, Weigand SD, Sintini I, Senjem ML, Ertekin-Taner N, Botha H, Utianski RL, Graff-Radford J, Jones DT, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Josephs KA.

Neurology. 2019 Feb 12;92(7):e710-e722. doi: 10.1212/WNL.0000000000006913. Epub 2019 Jan 11.

PMID:
30635491
13.

18 F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy.

Nedelska Z, Josephs KA, Graff-Radford J, Przybelski SA, Lesnick TG, Boeve BF, Drubach DA, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Whitwell JL, Kantarci K.

Mov Disord. 2019 Mar;34(3):344-352. doi: 10.1002/mds.27603. Epub 2019 Jan 7.

14.

Amyloid- and tau-PET imaging in a familial prion kindred.

Jones DT, Townley RA, Graff-Radford J, Botha H, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF.

Neurol Genet. 2018 Dec 3;4(6):e290. doi: 10.1212/NXG.0000000000000290. eCollection 2018 Dec.

15.

Cerebral microbleeds: Prevalence and relationship to amyloid burden.

Graff-Radford J, Botha H, Rabinstein AA, Gunter JL, Przybelski SA, Lesnick T, Huston J 3rd, Flemming KD, Preboske GM, Senjem ML, Brown RD Jr, Mielke MM, Roberts RO, Lowe VJ, Knopman DS, Petersen RC, Kremers W, Vemuri P, Jack CR Jr, Kantarci K.

Neurology. 2019 Jan 15;92(3):e253-e262. doi: 10.1212/WNL.0000000000006780. Epub 2018 Dec 19.

PMID:
30568001
16.

Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.

Sintini I, Schwarz CG, Martin PR, Graff-Radford J, Machulda MM, Senjem ML, Reid RI, Spychalla AJ, Drubach DA, Lowe VJ, Jack CR Jr, Josephs KA, Whitwell JL.

Hum Brain Mapp. 2019 Apr 1;40(5):1618-1631. doi: 10.1002/hbm.24473. Epub 2018 Dec 13.

PMID:
30549156
17.

Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods.

Gunter NB, Schwarz CG, Graff-Radford J, Gunter JL, Jones DT, Graff-Radford NR, Petersen RC, Knopman DS, Jack CR Jr.

Neuroimage Clin. 2019;21:101605. doi: 10.1016/j.nicl.2018.11.015. Epub 2018 Nov 19.

18.

Cognitive dysfunction in atrial fibrillation.

Madhavan M, Graff-Radford J, Piccini JP, Gersh BJ.

Nat Rev Cardiol. 2018 Dec;15(12):744-756. doi: 10.1038/s41569-018-0075-z. Review.

PMID:
30275499
19.

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging.

Vemuri P, Lesnick TG, Przybelski SA, Graff-Radford J, Reid RI, Lowe VJ, Zuk SM, Senjem ML, Schwarz CG, Gunter JL, Kantarci K, Machulda MM, Mielke MM, Petersen RC, Knopman DS, Jack CR Jr.

Ann Neurol. 2018 Nov;84(5):705-716. doi: 10.1002/ana.25346. Epub 2018 Oct 25.

20.

Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.

Ramanan VK, Przybelski SA, Graff-Radford J, Castillo AM, Lowe VJ, Mielke MM, Roberts RO, Reid RI, Knopman DS, Jack CR, Petersen RC, Vemuri P.

J Alzheimers Dis. 2018;65(4):1345-1352. doi: 10.3233/JAD-180446.

21.

Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.

Nedelska Z, Senjem ML, Przybelski SA, Lesnick TG, Lowe VJ, Boeve BF, Arani A, Vemuri P, Graff-Radford J, Ferman TJ, Jones DT, Savica R, Knopman DS, Petersen RC, Jack CR, Kantarci K.

Neuroimage Clin. 2018 Jun 19;19:939-947. doi: 10.1016/j.nicl.2018.06.020. eCollection 2018.

22.

18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus.

Townley RA, Botha H, Graff-Radford J, Boeve BF, Petersen RC, Senjem ML, Knopman DS, Lowe V, Jack CR Jr, Jones DT.

Neuroimage Clin. 2018 Feb 28;18:897-902. doi: 10.1016/j.nicl.2018.02.031. eCollection 2018.

23.

Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.

Tetzloff KA, Graff-Radford J, Martin PR, Tosakulwong N, Machulda MM, Duffy JR, Clark HM, Senjem ML, Schwarz CG, Spychalla AJ, Drubach DA, Jack CR, Lowe VJ, Josephs KA, Whitwell JL.

J Alzheimers Dis. 2018;62(4):1713-1724. doi: 10.3233/JAD-170740.

24.

Microinfarcts and blood pressure trajectories: response to Dr Niu et al.

Graff-Radford J, Rabinstein AA, Lesnick TG, Reichard RR, Knopman DS, Kantarci K.

J Hum Hypertens. 2018 May;32(5):385. doi: 10.1038/s41371-018-0058-x. Epub 2018 Apr 3. No abstract available.

PMID:
29610473
25.

Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.

Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda MM, Senjem ML, Spychalla AJ, Vemuri P, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA.

Alzheimers Dement. 2018 Aug;14(8):1005-1014. doi: 10.1016/j.jalz.2018.02.020. Epub 2018 Mar 30.

PMID:
29605222
26.

Clinicopathological and 123I-FP-CIT SPECT correlations in patients with dementia.

Jung Y, Jordan LG 3rd, Lowe VJ, Kantarci K, Parisi JE, Dickson DW, Murray ME, Reichard RR, Ferman TJ, Jones DT, Graff-Radford J, Savica R, Machulda MM, Fields JA, Allen LA, Drubach DA, St Louis EK, Silber MH, Jack CR Jr, Knopman DS, Petersen RC, Boeve BF.

Ann Clin Transl Neurol. 2018 Jan 24;5(3):376-381. doi: 10.1002/acn3.521. eCollection 2018 Mar.

27.

FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis.

Botha H, Mantyh WG, Murray ME, Knopman DS, Przybelski SA, Wiste HJ, Graff-Radford J, Josephs KA, Schwarz CG, Kremers WK, Boeve BF, Petersen RC, Machulda MM, Parisi JE, Dickson DW, Lowe V, Jack CR Jr, Jones DT.

Brain. 2018 Apr 1;141(4):1201-1217. doi: 10.1093/brain/awy049.

28.

Longitudinal tau PET in ageing and Alzheimer's disease.

Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, Machulda MM, Petersen RC.

Brain. 2018 May 1;141(5):1517-1528. doi: 10.1093/brain/awy059.

29.

[18 F]AV-1451 tau-PET and primary progressive aphasia.

Josephs KA, Martin PR, Botha H, Schwarz CG, Duffy JR, Clark HM, Machulda MM, Graff-Radford J, Weigand SD, Senjem ML, Utianski RL, Drubach DA, Boeve BF, Jones DT, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ, Whitwell JL.

Ann Neurol. 2018 Mar;83(3):599-611. doi: 10.1002/ana.25183. Epub 2018 Mar 13.

30.

In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.

Jones DT, Knopman DS, Graff-Radford J, Syrjanen JA, Senjem ML, Schwarz CG, Dheel C, Wszolek Z, Rademakers R, Kantarci K, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF.

Neurology. 2018 Mar 13;90(11):e947-e954. doi: 10.1212/WNL.0000000000005117. Epub 2018 Feb 9.

31.

Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.

Botha H, Mantyh WG, Graff-Radford J, Machulda MM, Przybelski SA, Wiste HJ, Senjem ML, Parisi JE, Petersen RC, Murray ME, Boeve BF, Lowe VJ, Knopman DS, Jack CR Jr, Jones DT.

Neurology. 2018 Mar 13;90(11):e940-e946. doi: 10.1212/WNL.0000000000005124. Epub 2018 Feb 7.

32.

Frequency of Acute and Subacute Infarcts in a Population-Based Study.

Arnold Fiebelkorn C, Vemuri P, Rabinstein AA, Mielke MM, Przybelski SA, Kantarci K, Jones DT, Brown RD Jr, Knopman DS, Petersen RC, Jack CR Jr, Graff-Radford J.

Mayo Clin Proc. 2018 Mar;93(3):300-306. doi: 10.1016/j.mayocp.2017.11.021. Epub 2018 Feb 14.

33.

The Heart-Brain Team-Towards Optimal Team-Based Coordinated Care.

Alkhouli M, Graff-Radford J, Holmes DR.

JAMA Cardiol. 2018 Mar 1;3(3):187-188. doi: 10.1001/jamacardio.2017.5072. No abstract available.

PMID:
29344618
34.

Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly.

Fatemi F, Kantarci K, Graff-Radford J, Preboske GM, Weigand SD, Przybelski SA, Knopman DS, Machulda MM, Roberts RO, Mielke MM, Petersen RC, Jack CR Jr, Vemuri P.

Neurology. 2018 Feb 6;90(6):e466-e473. doi: 10.1212/WNL.0000000000004913. Epub 2018 Jan 17.

35.

Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community-Based Cohort of Atrial Fibrillation.

Madhavan M, Hu TY, Gersh BJ, Roger VL, Killian J, Weston SA, Graff-Radford J, Asirvatham SJ, Chamberlain AM.

Mayo Clin Proc. 2018 Feb;93(2):145-154. doi: 10.1016/j.mayocp.2017.09.021. Epub 2018 Jan 9.

36.

[18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.

Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, Schwarz CG, Spychalla AJ, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA.

Ann Neurol. 2018 Feb;83(2):248-257. doi: 10.1002/ana.25142. Epub 2018 Feb 6.

37.

Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.

Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.

Brain. 2018 Jan 1;141(1):271-287. doi: 10.1093/brain/awx320.

38.

Association Between Microinfarcts and Blood Pressure Trajectories.

Graff-Radford J, Raman MR, Rabinstein AA, Przybelski SA, Lesnick TG, Boeve BF, Murray ME, Dickson DW, Reichard RR, Parisi JE, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

JAMA Neurol. 2018 Feb 1;75(2):212-218. doi: 10.1001/jamaneurol.2017.3392.

39.

Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.

Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, Botha H, Kantarci K, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Cortex. 2017 Dec;97:143-159. doi: 10.1016/j.cortex.2017.09.018. Epub 2017 Oct 3.

40.

The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.

Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW.

Alzheimers Dement. 2018 Mar;14(3):330-339. doi: 10.1016/j.jalz.2017.09.014. Epub 2017 Oct 31.

41.

Prevalence and Natural History of Superficial Siderosis: A Population-Based Study.

Pichler M, Vemuri P, Rabinstein AA, Aakre J, Flemming KD, Brown RD Jr, Kumar N, Kantarci K, Kremers W, Mielke MM, Knopman DS, Jack CR Jr, Petersen RC, Lowe V, Graff-Radford J.

Stroke. 2017 Dec;48(12):3210-3214. doi: 10.1161/STROKEAHA.117.018974. Epub 2017 Oct 25.

42.

Caudate nucleus as a component of networks controlling behavior.

Graff-Radford J, Williams L, Jones DT, Benarroch EE.

Neurology. 2017 Nov 21;89(21):2192-2197. doi: 10.1212/WNL.0000000000004680. Epub 2017 Oct 25. No abstract available.

43.

Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.

Roberts RO, Knopman DS, Syrjanen JA, Aakre JA, Vassilaki M, Kremers WK, Mielke MM, Machulda MM, Graff-Radford J, Geda YE, Vemuri P, Lowe V, Jack CR Jr, Petersen RC.

Neurology. 2017 Nov 14;89(20):2039-2048. doi: 10.1212/WNL.0000000000004652. Epub 2017 Oct 13.

44.

Age, vascular health, and Alzheimer disease biomarkers in an elderly sample.

Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Lowe VJ, Graff-Radford J, Roberts RO, Mielke MM, Machulda MM, Petersen RC, Jack CR Jr.

Ann Neurol. 2017 Nov;82(5):706-718. doi: 10.1002/ana.25071. Epub 2017 Oct 26.

45.

Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities).

Graff-Radford J, Simino J, Kantarci K, Mosley TH Jr, Griswold ME, Windham BG, Sharrett AR, Albert MS, Gottesman RF, Jack CR Jr, Vemuri P, Knopman DS.

Stroke. 2017 Nov;48(11):2964-2972. doi: 10.1161/STROKEAHA.117.018336. Epub 2017 Oct 10.

46.

Uptake of AV-1451 in meningiomas.

Bruinsma TJ, Johnson DR, Fang P, Senjem M, Josephs KA, Whitwell JL, Boeve BF, Pandey MK, Kantarci K, Jones DT, Vemuri P, Murray M, Graff-Radford J, Schwarz CG, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ.

Ann Nucl Med. 2017 Dec;31(10):736-743. doi: 10.1007/s12149-017-1205-0. Epub 2017 Sep 8.

PMID:
28887599
47.

Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation.

DeSimone CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, Asirvatham SJ, Holmes DR Jr.

J Am Coll Cardiol. 2017 Aug 29;70(9):1173-1182. doi: 10.1016/j.jacc.2017.07.724. Review.

48.

Cerebral amyloid angiopathy and implications for atrial fibrillation management.

DeSimone CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, Asirvatham SJ, Holmes DR Jr.

Lancet. 2017 Jul 1;390(10089):9-11. doi: 10.1016/S0140-6736(17)31326-0. No abstract available.

PMID:
28677558
49.

Author response: Mediodorsal nucleus and its multiple cognitive functions.

Golden EC, Graff-Radford J, Jones DT, Benarroch EE.

Neurology. 2017 Jul 4;89(1):107. doi: 10.1212/WNL.0000000000004077. No abstract available.

PMID:
28674162
50.

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Boeve BF, Graff-Radford J, Rocca WA, Mielke MM.

JAMA Neurol. 2017 Jul 1;74(7):839-846. doi: 10.1001/jamaneurol.2017.0603.

Supplemental Content

Loading ...
Support Center